Status:

COMPLETED

Macrophage Activation Markers in COVID-19 Patients

Lead Sponsor:

Sohag University

Conditions:

COVID-19

Eligibility:

All Genders

19-70 years

Brief Summary

This study is aiming to find the relation between the severity of COVID-19 in diabetic and obese patients and the high serum levels of matrix metalloproteinase-7 (MMP-7),matrix metalloproteinase-9 (MM...

Detailed Description

Acute respiratory distress syndrome (ARDS) commonly occurs in COVID-19 patients who are diabetic and obese, ARDS is characterized by inflammation and pulmonary fibrosis mediated by cytokines and bioma...

Eligibility Criteria

Inclusion

  • Overweight patients with body mass index higher than 25 and obese patients with body mass index higher than 30 were selected to be included
  • Type one and type two diabetes mellitus patients were also included

Exclusion

  • \-

Key Trial Info

Start Date :

April 25 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2021

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT04766294

Start Date

April 25 2020

End Date

April 1 2021

Last Update

June 24 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Faculty of medicine - sohag university

Sohag, Egypt, 82524

Macrophage Activation Markers in COVID-19 Patients | DecenTrialz